Interest of the Pleth Variability Index in Neurosurgery
Launched by NATIONAL INSTITUTE OF NEUROLOGY, TUNISIA · Sep 30, 2024
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients proposed for intracranial surgery
- • 2. Must be aged 18 and over
- • 3. Must be classified as ASA I, ASA II, and ASA III according to the American Society of Anesthesiologists classification
- Exclusion Criteria:
- • 1. Non-consenting patients
- • 2. Patients classified ASA IV or higher
- • 3. Cardiac arrhythmia
- • 4. Heart disease with left ventricular ejection fraction less than 45%
- • 5. Obesity with a BMI greater than 40 Kg/m2.
- • 6. Peripheral vascular disease
- • 7. Severe lung disease
- • 8. End-stage renal disease
- • 9. Intraoperative cardiac arrhythmia
- • 10. The occurrence of cardiac arrest
- • 11. The occurrence of hemorrhagic shock
- • 12. Intraoperative use of low tidal volumes or high respiratory rates.
About National Institute Of Neurology, Tunisia
The National Institute of Neurology in Tunisia is a leading research institution dedicated to advancing the understanding and treatment of neurological disorders. With a focus on innovative clinical trials, the institute aims to enhance patient care through rigorous scientific research and collaboration with national and international partners. By leveraging state-of-the-art facilities and a multidisciplinary team of experts, the National Institute of Neurology strives to contribute significantly to the field of neurology, ultimately improving outcomes for patients affected by neurological conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tunis, , Tunisia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported